A swallowable robot pill | The rise of PE in GI practices | Nearly half of physicians regret career choice | DDW'23
Praveen Suthrum
Cofounder, NextServices | Author, The Shift, Scope Forward | GI Mastermind
The bargaining chip gastroenterologists are using to command higher salaries (Becker’s GI & Endoscopy)
As the demand for gastroenterologists drives competition for talent among hospitals, ASCs and megagroups, GI physicians are bargaining for higher salaries.
Iterative Health Announces Upcoming U.S. Availability of SKOUT?: Real-Time AI for Polyp Detection?(Business Wire)
SKOUT, which is the only FDA-cleared device of its kind evaluated in a US-based clinical study population will serve gastroenterologists across the country by detecting more adenomas with real-time AI and preserving existing workflows.
GI Alliance Announces ASGE Group Partnership?(PR Newswire)
With the launch of this new institutional membership category, GI Alliance has become ASGE's first group member with the joint goal of advancing the practice of GI.
The Rise of Private Equity in Gastroenterology Practices?(Gastroenterology & Hepatology)
The article examines PE investment in gastroenterology practices and how this may impact the specialty in the future.
Among the various types of liability that physicians may face, including employee claims, HIPAA violations, cyber liability and slip-and-fall injuries, medical malpractice may be the most impactful.
A swallowable robot pill to examine the gastric cavity. Torrey Smith, founder and CEO of Endiatx talks about the journey building Pillbot and tiny robots in the human body?(GI StartUp Podcast)
In this episode, Torrey Smith discusses his journey from aerospace engineering, building Tesla coils at burning man, to founding Endiatx and making Pillbot; a pill-sized robot that can swim in the human stomach.
The partnership provides Ayble members an unprecedented level of dietary support for Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), and other chronic digestive conditions.
The procedures impacted by the new prior authorization policy will include diagnostic and surveillance colonoscopies, esophagogastroduodenoscopies (EGD) and capsule endoscopies, a UnitedHealthcare release stated.
Lynx.MD Partners with Prometheus Laboratories and Gastro Health to Leverage Medical Data Intelligence Platform for IBD?(DigitalJournal)
The partnership will bring together 10-years of de-identified IBD clinical laboratory data and patient data, using the Lynx Trusted Data Environment, to research and demonstrate the value of the Prometheus Anser? IFX therapeutic drug monitoring test.
领英推荐
Can My Practice Benefit From CON Regulations??(Rockett Healthcare)
Certificate of Need (CON) regulations are in place for ambulatory surgery centers (ASC) in about 20 states. For most physicians, these regulations stop them from forming their own ASC due to the high cost and complexity of coming into compliance.
The deal marks a significant turning point in the healthcare consolidations of the past two decades, albeit a perplexing one.
Guidelines that recommend stool-based screening for colorectal cancer should emphasize strict adherence and offer screening colonoscopy as an alternative option, researchers reported in Gastroenterology.
Outperforming Human Pathologists – New Harvard-Developed AI Tool Predicts Colon Cancer Survival, Treatment Response?(SciTech Daily)
The new tool can accurately predict the aggressiveness of a colorectal tumor, the likelihood of survival with and without disease recurrence.
FDA: The heart-checking smart toilet seat is a go?(Fierce Biotech)
The battery-powered, Internet-connected Heart Seat is designed to replace a standard home toilet seat, automatically capturing and uploading SpO2 and heart rate data.
Recent studies have indicated that using adenoma per colonoscopy as a metric could help better forecast the risk of colon cancer.
Nearly half of physicians regret career choice: Here's how to fix it (Becker’s Healthcare)
With physician burnout rates at an all-time high, here are six ways for leaders to bring satisfaction back to the practice, per the AMA.
DDW23: Endoscopic ReCET Procedure Plus Semaglutide Eliminates Need for Insulin in Type 2 Diabetes?(Medical Research)
An investigational outpatient endoscopic procedure may help eliminate the need for insulin in people with type 2 diabetes, early research has suggested.
The article reviews current bowel prep options, safety considerations, and best practice recommendations.
For weekly gastroenterology business/tech updates directly in your inbox, subscribe to the?Scope Forward newsletter.